Related Experiment Videos
A surveillance study on penicillin-resistant streptococcus pneumoniae in China
1Institute of Clinical Pharmacology, First Teaching Hospital of Beijing Medical University, Beijing 100034, China.
Chinese Medical Journal
|October 17, 2001
Summary
Penicillin-resistant Streptococcus pneumoniae strains have been identified in China, with high resistance rates to macrolides and tetracycline observed in pediatric patients. This highlights a growing concern for antimicrobial resistance in the region.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Streptococcus pneumoniae is a common cause of pediatric respiratory infections.
- Antimicrobial resistance in S. pneumoniae is a significant global health concern.
- Surveillance of antibiotic resistance patterns is crucial for effective treatment strategies.
Purpose of the Study:
- To determine the prevalence of penicillin-resistant Streptococcus pneumoniae in China.
- To assess the resistance rates of S. pneumoniae to various antimicrobial agents.
- To identify resistance patterns in pediatric patients with respiratory tract infections.
Main Methods:
- A surveillance study was conducted in Beijing, China, involving over 900 pediatric patients.
- Throat swabs were collected and isolates were identified as S. pneumoniae.
- Antibiotic susceptibility testing was performed using disk diffusion and MIC determination.
Main Results:
- Two of 51 S. pneumoniae isolates exhibited penicillin resistance (MICs of 2 mg/L and 4 mg/L).
- High resistance rates were observed for macrolides (erythromycin, clarithromycin, roxithromycin) and tetracycline (100%).
- Resistance to ampicillin, piperacillin, furbenicillin, and cefuroxime was also noted.
Conclusions:
- Penicillin-resistant Streptococcus pneumoniae strains are present in China.
- These resistant strains show cross-resistance to other beta-lactams and high resistance to macrolides and tetracycline.
- The findings underscore the need for ongoing surveillance and updated treatment guidelines for pneumococcal infections in China.